Drug-induced hypersensitivity syndrome caused by carbamazepine used for the treatment of trigeminal neuralgia

Yuko Ono, Tsuyoshi Shimo, Yoshinori Shirafuji, Toshihisa Hamada, Masanori Masui, Kyoichi Obata, Mayumi Yao, Koji Kishimoto, Akira Sasaki

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

An 88-year-old man was diagnosed with trigeminal neuralgia, and treatment of carbamazepine 200 mg/day was initiated. About 6 weeks later, the patient developed a skin rash accompanied by fever. He was admitted to hospital and diagnosed with drug-induced hypersensitivity syndrome (DIHS) caused by carbamazepine. Oral carbamazepine treatment was stopped, but blood tests showed acute liver and acute renal failure. Drug-induced lymphocyte stimulation test (DLST) for carbamazepine, human herpes virus-6 (HHV-6) IgG, and CMV-HRP were negative. Oral prednisolone therapy was begun 18 days later. The titer of HHV-6 IgG antibodies was then detected (640 times). Following treatment, liver and renal function improved and the erythema disappeared.

Original languageEnglish
Article number4605231
JournalCase Reports in Dentistry
Volume2016
DOIs
Publication statusPublished - 2016

ASJC Scopus subject areas

  • Dentistry(all)

Fingerprint Dive into the research topics of 'Drug-induced hypersensitivity syndrome caused by carbamazepine used for the treatment of trigeminal neuralgia'. Together they form a unique fingerprint.

  • Cite this